Trial intelligence / Profile preview

Resveratrol in Ischemic Stroke

IRCT20191020045162N1Phase 3Completed

Sponsor
Kermanshah University of Medical Sciences
Start
Nov 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of resveratrol in ischemic stroke, sponsored by Kermanshah University of Medical Sciences. Started Nov 2019; status: completed.

02

Drugs

resveratrol
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on IRCT20191020045162N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20191020045162N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call